Rotavirus diarrhea in Bangladeshi children: correlation of disease severity with serotypes.
To improve the understanding of the relative importance of serotypes of rotavirus in dehydrating diarrhea, we examined the correlation of clinical characteristics and disease severity with serotype in 2,441 diarrheal episodes among children younger than 2 years of age in rural Bangladesh. Of 764 rotavirus-associated episodes, a single G type (serotype 1, 2, 3, or 4) was determined by oligonucleotide probe in 485 (63%), while 233 episodes were nontypeable. Episodes with G types 2 and 3 were associated with more-severe dehydration than episodes associated with G type 1 or 4 or with nontypeable rotavirus. Episodes did not differ by G type in prevalence of vomiting, copious diarrhea, fever, abdominal pain, or length of treatment center stay. Rotavirus reinfections were detected in seven children, with homologous reinfection (G type 2) in one. Twelve children with diarrhea who died had rotavirus detected in stool specimens within 30 days of death. Children who died were more likely to be malnourished than were surviving children with rotavirus diarrhea. Of 40 specimens tested by polymerase chain reaction, 29 (72.5%) were P type 1, 9 (22.5%) were P type 2, 1 (2.5%) was P type 3, and 1 (2.5%) was nontypeable. One severely symptomatic diarrheal episode was associated with P type 3 rotavirus, a serotype usually found in asymptomatic nursery infections. Although G types 2 and 3 were associated with more-severe dehydration than other serotypes, the differences do not appear to be of major clinical importance. Effective vaccines should protect against all four major G types.
Bern
C
C
Viral Gastroenteritis Section, National Center for Infectious Diseases, Centers for Disease Control, Atlanta, Georgia 30333.
Unicomb
L
L
Gentsch
J R
JR
Banul
N
N
Yunus
M
M
Sack
R B
RB
Glass
R I
RI
D001459:Bangladesh / Q000453:epidemiology; D003967:Diarrhea / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D012401:Rotavirus / Q000145:classification* / Q000472:pathogenicity; D012400:Rotavirus Infections / Q000453:epidemiology / Q000382:microbiology* / Q000517:prevention & control; D016036:Seroepidemiologic Studies; D012703:Serotyping; D014765:Viral Vaccines / Q000302:isolation & purification
D014765:Viral Vaccines